Demise of the life science company begins

Article Abstract:

Basel, Switzerland-based Novartis and London, UK-based AstraZeneca recently announced that they plan to spin off and merge their agrochemical divisions. The company formed by this move will be called Syngenta.

Switzerland, Organizational history, Chemicals & Allied Products, Chemical Manufacturing, Agricultural Chemicals, Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing, Chemicals, Novartis AG, AstraZeneca PLC, Syngenta AG

---

Biotech companies adapt to big pharma mergers

Article Abstract:

Biotechnology companies in the U.S. and Europe are drawing up licensing contracts to protect already-existing research partnerships in light of the increasing trend of mergers among pharmaceutical companies.

Contracts & orders received, Drugs

---

Genzyme acquires Cell Genesys

Article Abstract:

In October, Genzyme (Cambridge, MA) paid $350m to acquire Cell Genesys (Foster City, CA), and its 500+ patents in gene and protein therapy, along with various drugs in trial, including cancer drugs.

Asset sales & divestitures, Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences, Biological Product (except Diagnostic) Manufacturing, Biological Products, Genzyme Corp., Cell Genesys Inc.

Similar abstracts:

• Abstracts: Biocompatibles International. Biocompatibles heads for the heart
• Abstracts: Information technology as competitive advantage: the role of human, business, and technology resources. Competitive advantage: logical and philosophical considerations
• Abstracts: European equities cheap - but not nasty. European alliance. The European domino effect
• Abstracts: The end of the human touch? Playing the field
• Abstracts: A genetic heritage betrayed or empowered? Johnson & Johnson acquires Centocor. Scientists avert new GMO crisis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.